Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study

Trial Identifier:	D822EC00001
Sponsor:	AstraZeneca
Start Date:	June 2023
Primary Completion Date:	May 2026
Study Completion Date:	May 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Japan	Chiba, Japan
Japan	Miyazaki, Japan
Japan	Nagano, Japan
Japan	Okayama, Japan
Japan	Shizuoka, Japan
Japan	Yamanashi, Japan

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.